The conference will include 3 tracks:
Scientific presentations from leaders in the field
Daily Working Group Updates and Discussion Sessions on Precision Medicine for:
Short Oral Presentations (E-posters) with mentored discussions, with focus on early career participants, mentorship and meet-the-professor sessions
Legend
- Plenary Sessions
- Workshops
Each day of the virtual conference will include a series of plenary talks from key stakeholders and experts in various aspects of precision diabetes medicine, followed by a featured keynote talk from an individual living with diabetes. The Virtual Poster Hall will be open during the entirety of the virtual event to showcase scientific efforts in the field.
Time (EDT) | Session / Topic | Chair / Speaker |
---|---|---|
8:00-10:00 | Vision and Direction of the Precision Medicine for Diabetes Initiative | John Nolan, MD & Christine Lee, MD |
08:00-08:10 | Welcome and opening remarks | Tracey Brown, CEO, American Diabetes Association |
08:10-08:20 | Opening remarks | Stefano Del Prato, President, European Association for the Study of Diabetes |
08:20-08:40 | Keynote: The Precision Medicine in Diabetes Initiative – Treating the Whole Person | Robert Gabbay, Chief Scientific and Medical Officer, American Diabetes Association |
08:40-09:00 | Keynote: Real Life Needs of People with Diabetes | Dana Lewis, US, living with type 1 diabetes |
09:00-09:20 | Precision Medicine and the Research Agenda for Diabetes | William Cefalu, Director, Division of Diabetes, Endocrinology and Metabolic Disease, NIDDK |
09:20-09:40 | The Precision Medicine in Diabetes Initiative – Vision and Future Direction | Paul Franks, Co-chair, ADA/EASD Precision Medicine in Diabetes Initiative |
09:40-10:00 | A Vision for Future Diabetes Care based on Precision | Martin Ridderstråle, Senior Vice President and Head of Patient Care, Novo Nordisk Foundation |
10:00-11:00 | Moderated, Early-Career Poster Presentations | Bob Eckel, MD |
10:00-10:05 | Longitudinal phenotypes of type 1 diabetes in youth based on weight and glycemia and their association with complications | Anna Kahkoska |
10:05-10:10 | Comparison of Four Risk Prediction Models for Diabetes Remission After Roux-en-Y Gastric Bypass Surgery in Obese Chinese Patients with Type 2 Diabetes Mellitus | Kam Hoi Man |
10:10-10:15 | Genome-wide association study reveals genetic overlap between placental weight, birth weight and diabetes. | Christopher Flatley |
10:15-10:20 | Precision medicine in type 2 diabetes: Predictors of differential HbA1c response to SGLT2-inhibitors identified in primary care data are replicated in EMPA-REG OUTCOME trial data | Katherine Young |
10:20-10:25 | In vitro functional analysis of human HNF1B variants aid variant interpretation and clinical diagnostics | Aishwarya Pavithram |
10:25-10:30 | A type 1 diabetes diagnostic model including type 1 diabetes genetic risk score and clinical features aids in classification of adult patients with clinical type 1 diabetes that are islet autoantibody negative | Josefine Tecklenborg |
10:30-10:35 | The interplay between polygenic and rare HNF1A variant risk in type 2 diabetes. | Lauren Stalbow |
10:35-10:40 | Genetics and Clinical Characteristics of PPARG Variants Induced Diabetes in a Chinese Han Population | Siqian Gong |
10:40-10:45 | Prognostic markers of diabetes-associated mortality in clinical notes: a retrospective cohort analysis using machine learning and unstructured big data | Kushan De Silva |
10:45-11:00 | Precision diagnostics in diabetes: Unraveling the disease causality of HNF1B coding variants in two large Norwegian diabetes registries | Ingvild Losnegard Koløen |
9:00-11:30 | Clinical and Scientific Challenges and Opportunities for Precision Diabetes Medicine | Ruth Weinstock, MD, PhD & Anna Kahkoska, PhD |
09:00-09:15 | Keynote: Personalizing Diabetes Care in 2021 | John Buse, Chief, Division of Endocrinology, University of North Carolina at Chapel Hill |
09:15-09:30 | Keynote: Living and staying healthy with type 2 diabetes | Adithya Menon, India, living with type 2 diabetes |
09:30-09:50 | Precision Diabetes in South Asians | V Mohan, Chair, Dr Mohan’s Diabetes Specialties Centre, Chennai, India |
09:50-10:10 | Sub-classification of diabetes: Possibilities and Challenges | Miriam Udler, Massachusetts General Hospital and Broad Institute, Boston, US |
10:10-10:30 | Precision Approach to Diabetes in Pregnancy | Marie-France Hivert, Dept of Population Medicine, Harvard Medical School |
10:30-10:50 | Approach to Precision Medicine for ‘Common’ Type 2 diabetes | Chris Rhodes, Chief Scientist, Cardiovascular, Renal and Metabolism, Astra Zeneca, Gaithersburg, MD, US |
10:50-11:10 | Precision Prevention of Type 1 Diabetes | Jessica Dunne, Janssen Pharmaceuticals, New Jersey, US |
11:10-11:30 | Panel discussion |
9:00-11:20 | From History to Future Policy— Broader Context for Precision Diabetes Medicine | Chairs: Cynthia Muñoz, PhD, MPH & Zhila Semnani-Azad, BSc |
09:00-09:15 | Keynote: Precision Diabetes Care – a historical perspective on race and disease | Arleen Tuchman, Nelson O. Tyrone Jr. Professor of History, Vanderbilt University |
09:15-09:30 | Keynote: The Importance of the Diagnosis | Kristin Skiados, living with monogenic diabetes |
09:30-09:50 | Precision Monitoring and Technology in Diabetes Care | David Klonoff, Director, Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California |
09:50-10:10 | Precision Monitoring – Approach to Policy Implementation | Dirk Mueller-Wieland, Head Clinical Research Centre, Dept of Medicine, University of Aachen, Germany |
10:10-10:30 | Public-private partnerships in the research approach to Precision Medicine | Bernd Stowasser, Sanofi, IMI Strategic Governance Group, Diabetes & Metabolic Disorders |
10:30-10:50 | The Accelerating Medicines Partnership in Type 2 Diabetes. | Philip Smith, Division of Diabetes, Endocrinology & Metabolic Diseases, NIDDK |
10:50-11:10 | Thoughts on Precision Medicine in Diabetes: an industry perspective | Rasmus Rabøl, CVP, Novo Nordisk |
11:10-11:20 | Panel discussion | |
11:20-11:30 | Closing Remarks | Paul Franks, PhD & John Nolan, MD |